7Baggers

NextDecade Corporation
(NASDAQ:NEXT) 

NEXT stock logo

NextDecade Corporation, a liquefied natural gas (LNG) development company, engages in the development activities related to the liquefaction and sale of LNG. It focusses on the development activities of Rio Grande LNG terminal facility located in the Port of Brownsville, southern Texas. The company ...

Founded: 2010
Full Time Employees: 74
Sector: Energy
Industry: Oil & Gas E&P
Energy
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 
                                      
      revenues
    		                                  
      operating expenses:
    		                                  
      general and administrative expense
    		49,941,000 39,189,000 66,105,000 44,942,000 40,104,000 43,598,000 33,902,000 32,505,000 26,273,000 32,128,000 26,795,000 26,271,000 7,308,250 14,616,000 11,293,000 3,323,000 2,710,000 2,937,000 6,533,000 1,369,000 4,145,500 5,069,000 4,700,000  2,601,250 3,579,000 -5,076,000        
      development expense
    		2,143,000 3,570,000 2,881,000 307,000 956,000 2,386,000 2,409,000 2,509,000 2,926,000 1,083,000 418,000 464,000 231,000 1,133,000 1,193,000 1,545,000                   
      depreciation and amortization expense
    		3,031,000 3,025,000 2,977,000 3,149,000                               
      other
    		   3,518,000 -102,000 1,719,000 -1,066,000 455,000 1,410,250 5,682,000 192,000 130,000 65,000 65,000 20,000 1,000     -1,000 -1,000  -17,000 -195,000 -7,000 94,000 176,000 -83,000  3,000    
      total operating expenses
    		55,115,000 45,784,000 71,963,000 51,916,000 44,268,000 49,156,000 39,534,000 38,117,000 32,146,000 35,835,000 27,576,000 27,110,000 20,435,000 16,089,000 12,818,000 5,134,000 7,853,000 3,220,000 6,812,000 1,621,000 4,003,000 5,557,000 5,211,000 7,241,000 12,519,000 4,413,000 5,581,000 12,488,000 12,140,000 10,979,000 3,616,000 16,280,000 16,435,000 14,290,000 
      total operating loss
    		-55,115,000 -45,784,000 -71,963,000 -51,916,000 -44,268,000 -49,156,000 -39,534,000 -38,117,000 -32,146,000 -35,835,000 -27,576,000 -27,110,000 -20,435,000 -16,089,000 -12,818,000 -5,134,000 -7,853,000 -3,220,000 -6,812,000 -1,621,000 -4,003,000 -5,557,000 -5,211,000 -7,241,000 -12,519,000 -4,413,000 -5,581,000 -12,488,000 -12,140,000 -10,979,000 -3,616,000 -16,280,000 -16,435,000 -14,290,000 
      other income:
    		                                  
      derivative loss
    		-62,110,000          -87,450,000                        
      interest expense
    		-79,247,000 -75,341,000 -38,632,000                                
      other income
    		1,432,000 6,404,000 -20,000 2,593,000                               
      total other income
    		-139,925,000   -193,312,000 525,711,000 -343,919,000 41,838,000 224,892,000 31,182,500 217,679,000       -170,000 4,442,000 -4,768,000 -2,037,000 1,724,000 -1,621,000 -563,000 8,143,000 -1,362,000 1,185,000 -1,138,000 445,000 542,000 299,000 134,000 80,000 107,000 133,000 
      income before income taxes
    		-195,040,000                                  
      income tax expense
    		                                  
      net income
    		-195,040,000                              -3,482,000 -16,200,000 -16,328,000 -14,157,000 
      yoy
    		                                  
      qoq
    		                              -78.51% -0.78% 15.34%  
      less: net loss attributable to non-controlling interests
    		-58,634,000                                  
      net loss attributable to common stockholders
    		-136,406,000 -47,280,000 -109,482,000    -32,576,000    -127,043,000 -34,047,000 -25,430,000 -25,045,000 -16,686,000 -17,191,000 -13,318,000 -4,058,000 -15,471,000 -7,549,000 -6,056,000 -10,807,000 -9,304,000 -2,617,000 -17,417,000 -6,363,000 -7,207,000 -17,566,000 -12,873,000 -10,951,000     
      loss per common share — basic & diluted
    		-510                                  
      weighted-average shares outstanding — basic & diluted
    		264,908,000                                  
      derivative gain
    		 206,678,000 -74,141,000 -168,700,000 548,335,000 -329,733,000 109,067,000 258,872,000 38,204,000 240,265,000                         
      loss on debt extinguishment
    		 -2,290,000   -1,741,000  -40,133,000 -7,440,000                           
      total other expense
    		 -80,117,250 -112,793,000        -92,713,000 -237,000 1,510,000 -2,708,000 1,906,000 -6,303,000                   
      net loss attributable to nextdecade corporation
    		 -125,154,000 -184,756,000        -120,289,000 -27,347,000 -18,925,000 -18,797,000 -10,912,000 -11,437,000   -11,580,000  -2,279,000 -7,178,000 -5,774,000  -13,881,000 -3,228,000 -6,719,000 -12,043,000 -11,598,000 -10,680,000     
      less: net loss attributable to non-controlling interest
    		 -60,365,500 -75,274,000                                
      net loss per common share — basic and diluted
    		 -247.5 -420                                
      weighted-average shares outstanding — basic and diluted
    		  262,581,000                                
      interest expense, net of capitalized interest
    		   -27,205,000 -20,125,000 -15,905,000 -26,030,000 -25,479,000 -17,749,000 -32,536,000                         
      net income attributable to nextdecade corporation
    		   -245,228,000 481,443,000 -393,075,000 2,304,000 186,775,000 8,552,000 181,844,000       -3,504,000 1,222,000      902,000           
      less: net income attributable to non-controlling interest
    		   -156,423,000 415,765,000 -269,876,000 34,880,000 158,429,000 16,801,000 67,204,000                         
      net income attributable to common stockholders
    		   -88,805,000 -31,857,250 -123,199,000  28,346,000 -13,370,000 107,610,000                         
      net income per common share — basic and diluted
    		   -340                               
      weighted-average shares outstanding — basic
    		   260,405,000                               
      weighted-average shares outstanding — diluted
    		   260,405,000                               
      lease expense
    		    2,594,000 2,559,000 2,603,000 3,019,000 2,896,000 2,582,000 325,000 337,000 311,000 299,000 290,000 219,000                   
      depreciation expense
    		    614,000 613,000 620,000 84,000 51,000 42,000 38,000 38,000 33,000 41,000 42,000 47,000 48,000 43,000 45,000 48,000 50,000 65,000 64,000 16,000 87,000 80,000 43,000 41,000 44,000 50,000 48,000 29,000 28,000 26,000 
      less: preferred stock dividends
    		         7,030,000                         
      net income per common share - basic and diluted
    		    -122.5 -470  110                           
      weighted-average shares outstanding - basic and diluted
    		     259,379,000 257,842,000    150,933,000 146,931,000 130,136,000 129,418,000 126,314,000 121,328,000 119,201,000 119,374,000 118,382,000 118,262,000 117,524,000 117,564,000 117,388,000 117,353,000 109,057,000 107,181,000 107,061,000 106,940,000 106,564,000 106,639,000 106,398,000 106,388,000 100,926,000 103,870,000 
      net loss per common share - basic and diluted
    		      -130    -840 -230 -180 -190 -130 -140 -110 -30 -130 -60 -50 -90 -80 -20 -160 -60 -70 -160 -120 -100 -30 -150 -160 -140 
      loss on common stock warrant liabilities
    		       -1,516,000    -367,000    -6,304,000           -1,641,000 -197,000       
      weighted-average shares outstanding - basic
    		       256,707,000  222,466,000                         
      weighted-average shares outstanding - diluted
    		       266,886,000  226,336,000                         
      operating expenses
    		                                  
      gain on common stock warrant liabilities
    		        -630,000 3,302,000   -1,798,000 -2,773,000 1,886,000  -170,000 4,442,000 -4,768,000 -2,038,000 1,723,000 -1,627,000 -565,000 8,339,000 -1,692,000 873,000   81,000 83,000     
      interest income
    		        332,250 966,000          1,000 2,000 7,000 2,000 233,000 525,000 319,000 409,000 466,000 544,000 222,000 131,000 122,000 107,000 145,000 
      net income per common share - basic
    		        -77.5 480                         
      net income per common share - diluted
    		        -77.5 480                         
      gain on common stock warrant liabilities
    		          -5,455,000                        
      preferred stock dividends
    		          -6,754,000 -6,700,000 -6,505,000 -6,248,000 -5,774,000 -5,754,000 -5,279,000 -5,264,000 -3,876,000 -3,875,000 -3,762,000 -3,613,000 -3,509,000 -3,443,000 -3,343,000 -2,849,000  -4,972,000       
      deemed dividends on series a convertible preferred stock
    		                -16,000 -16,000 -15,000 -16,000 -15,000 -16,000 -21,000 -76,000 -193,000 -286,000 -488,000 -551,000 -1,093,000 271,000     
      land option and lease expense
    		                169,500 240,000 234,000 204,000 320,250 423,000 447,000  437,500 754,000 451,000        
      loss on redemption of investment securities
    		                       -412,000           
      net ( loss) income attributable to nextdecade corporation
    		                   -3,658,000               
      invitation to bid contract costs
    		                          10,163,000  2,145,000 4,418,000     
      general and administrative expenses
    		                       6,814,000    12,019,000 9,649,000 6,214,000 3,318,000 16,001,000   
      land option and lease expenses
    		                       411,000    428,000 302,000 297,000 250,000 250,000 248,000 250,000 
      operations
    		                                  
      comprehensive loss
    		                            -11,598,000 -10,680,000 -3,482,000 -16,200,000 -16,350,000 -14,151,000 
      other comprehensive loss:
    		                                  
      change in fair value of investments
    		                                -22,000 6,000 
      other expense
    		                               -42,000  -12,000 
      general and administrative
    		                                4,598,000 14,014,000 
      impairment loss on capital projects
    		                                  
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-09-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 
                                                
        assets
      		                                          
        current assets:
      		                                          
        cash and cash equivalents
      		143,120,000 209,402,000 130,938,000 148,137,000 38,230,000 38,142,000 45,753,000 38,241,000 50,847,000 40,012,000 51,141,000 62,789,000 109,223,000 40,500,000 22,358,000 25,552,000 36,743,000 40,595,000 39,290,000 22,608,000 29,933,000 37,579,000 58,279,000 15,736,000 3,841,000 4,543,000 5,569,000 3,169,000 33,880,000 18,846,000 24,705,000 35,703,000  50,539 196,517 34,940 113,704 157,422 324,991 379,939 479,086 878,685 
        restricted cash
      		321,943,000 535,272,000 255,209,000 244,625,000 227,568,000 164,937,000 205,645,000 256,237,000 395,012,000                                  
        derivatives
      		13,202,000 9,680,000 14,270,000 16,867,000 4,253,000 18,873,000 29,327,000                                    
        prepaid expenses and other current assets
      		9,255,000 10,465,000 4,368,000 2,943,000 1,322,000 2,103,000 3,193,000 2,089,000 2,270,000 13,328,000 1,570,000 1,149,000 1,309,000 1,001,000 1,029,000 835,000 883,000 763,000 818,000 670,000 800,000 878,000 1,079,000 859,000 1,288,000 1,755,000 1,781,000 1,310,000 1,804,000 2,195,000 2,282,000 2,099,000 1,043,000          
        total current assets
      		487,520,000 764,819,000 404,785,000 412,572,000 271,373,000 224,055,000 283,918,000 314,525,000 469,176,000 53,340,000 52,711,000 63,938,000 110,532,000 41,501,000 23,387,000 26,387,000 37,626,000 41,358,000 40,108,000 23,278,000 30,733,000 38,457,000 59,358,000 78,802,000 45,503,000 58,871,000 63,438,000 76,932,000 95,819,000 26,129,000 32,052,000 42,865,000 50,812,000          
        property, plant and equipment
      		11,663,941,000 8,470,021,000 5,702,709,000 5,020,003,000 4,329,376,000 3,733,783,000 3,158,242,000 2,437,733,000 1,713,796,000 266,427,000 243,870,000 218,646,000 182,818,000 177,420,000 175,172,000 173,816,000 170,431,000 168,176,000 164,205,000 161,662,000 158,363,000 150,051,000 146,012,000 134,591,000 119,918,000 104,198,000 96,026,000 92,070,000 88,870,000 86,060,000 79,364,000 73,226,000 67,602,000          
        operating lease right-of-use assets
      		135,147,000 163,577,000 164,995,000 166,082,000 167,168,000 168,255,000 169,504,000 170,827,000 172,146,000 951,000 1,216,000 1,474,000 1,065,000 1,257,000 450,000 590,000 727,000 860,000 290,000 429,000 675,000 1,004,000 730,000 1,054,000 1,336,000 1,608,000 1,378,000                
        deferred financing fees
      		393,489,000 244,521,000 292,971,000 317,788,000 340,488,000                                      
        other non-current assets
      		50,436,000 36,349,000 24,996,000 15,557,000 15,557,000 15,556,000 17,054,000 11,021,000 11,021,000 32,068,000 30,108,000 28,372,000 26,301,000 24,566,000 22,661,000  19,903,000 18,695,000 17,478,000  15,096,000 13,917,000 12,677,000  3,071,000                  
        total assets
      		13,231,740,000 10,008,819,000 6,893,670,000 6,404,059,000 5,123,962,000 4,757,174,000 4,175,883,000 3,323,801,000 2,898,416,000 352,786,000 327,905,000 312,430,000 320,716,000 244,744,000 221,670,000 222,105,000 228,687,000 229,089,000 222,081,000 201,668,000 204,867,000 203,429,000 218,777,000 221,195,000 169,828,000 164,677,000 160,842,000 169,002,000 184,689,000 112,189,000 111,416,000 116,091,000 118,763,000          
        liabilities and equity
      		                                          
        current liabilities:
      		                                          
        accounts payable
      		298,124,000 428,860,000 256,765,000 244,642,000 224,358,000 131,800,000 175,384,000 243,129,000 326,818,000 12,815,000 1,854,000 1,084,000 4,887,000 1,456,000 516,000 281,000 744,000 200,000 224,000 207,000 561,000 519,000 3,873,000 11,912,000 1,400,000 1,856,000 1,513,000 719,000 991,000 623,000 247,000 726,000 1,820,000 484,072 372,495 33,920 21,759 53,193 17,259 17,259 58,509 81,977 
        operating leases
      		1,294,000 3,296,000 2,847,000  2,887,000 2,846,000 2,972,000                                    
        accrued and other current liabilities
      		914,940,000 761,817,000 216,068,000 347,561,000 331,029,000 364,909,000 321,997,000 299,264,000                                   
        total current liabilities
      		1,214,358,000 1,193,973,000 475,680,000 595,084,000 558,274,000 499,555,000 505,650,000 552,387,000 550,667,000 45,308,000 34,892,000 25,361,000 17,025,000 7,916,000 7,244,000 8,226,000 8,141,000 14,331,000 7,347,000 5,143,000 7,368,000 2,633,000 13,234,000 21,543,000 23,005,000 8,611,000 7,422,000 12,090,000 21,941,000 18,063,000 7,665,000 8,397,000 6,918,000          
        debt
      		9,355,258,000 6,609,434,000 4,549,202,000 3,920,425,000 3,315,150,000 2,833,809,000 2,393,730,000 1,816,301,000                                   
        total liabilities
      		10,871,596,000 8,032,472,000 5,170,132,000 4,659,673,000 4,078,231,000 3,478,390,000 3,044,846,000 2,583,367,000 2,080,781,000 156,604,000 61,940,000 55,616,000 48,402,000 36,741,000 37,864,000 33,813,000 33,773,000 40,732,000 32,846,000 28,933,000 30,271,000 22,060,000 31,930,000 33,580,000 33,358,000 20,100,000 15,412,000 19,531,000 29,463,000 18,063,000 12,084,000 12,999,000 10,245,000 6,349,576 5,330,114 4,358,920 4,346,759 4,378,193 4,342,259 4,342,259 4,383,509 4,532,651 
        commitments and contingencies
      		                                          
        equity:
      		                                          
        common stock, 0.0001 par value...
      		27,000 26,000 26,000 26,000 26,000 26,000 26,000 26,000       12,000                            
        treasury stock
      		-37,880,000 -36,478,000 -20,965,000 -20,916,000 -20,791,000 -14,367,000 -14,308,000 -14,214,000 -14,194,000 -4,657,000 -4,634,000 -4,587,000 -4,127,000 -3,067,000 -1,779,000 -1,315,000 -1,310,000 -1,171,000 -1,075,000 -1,031,000 -1,007,000 -796,000 -742,000 -685,000 -685,000 -466,000 -295,000 -35,000 -19,000              
        preferred stock, 0.0001 par value...
      		                                          
        additional paid-in-capital
      		903,508,000 903,614,000 865,745,000 852,054,000 1,209,753,000 1,043,307,000 897,805,000 693,883,000 753,673,000 362,735,000 318,942,000 289,084,000 291,684,000 213,749,000 183,138,000 191,264,000 195,136,000 199,553,000 202,176,000 209,481,000 212,807,000 215,807,000 218,972,000 224,091,000 162,590,000 170,374,000 183,834,000 180,862,000 176,274,000 169,454,000 171,178,000 158,738,000 147,814,000          
        accumulated deficit
      		-896,363,000 -712,677,000 -542,328,000 -453,523,000 -519,201,000 -396,002,000 -363,426,000 -391,772,000 -262,507,000 -377,776,000 -257,487,000 -230,140,000 -211,215,000 -192,418,000 -181,506,000 -170,069,000 -162,046,000 -163,268,000 -151,688,000 -148,030,000 -145,751,000 -138,573,000 -132,799,000 -133,701,000 -119,820,000 -116,592,000 -109,873,000 -97,617,000 -86,019,000 -75,339,000 -71,857,000 -55,617,000 -39,289,000 -989,641 -881,420 -540,319 -485,834 -420,715 -264,510 -191,640 -101,899 -9,516 
        total stockholders’ equity
      		-30,708,000 154,485,000 302,478,000  669,787,000 632,964,000 520,097,000   -19,682,000 56,836,000 54,371,000 76,356,000 18,277,000 -135,000 19,892,000 31,792,000 35,126,000 49,425,000 60,432,000 66,061,000 76,450,000 85,443,000 89,717,000 42,096,000 53,327,000 73,677,000 83,221,000 90,247,000 94,126,000 99,332,000 103,092,000 108,518,000 5,000,001         
        non-controlling interests
      		2,390,852,000                                          
        total equity
      		2,360,144,000 1,976,347,000 1,723,538,000 1,744,386,000 1,045,731,000 1,278,784,000 1,131,037,000 740,434,000 817,635,000                                  
        total liabilities and equity
      		13,231,740,000 10,008,819,000 6,893,670,000 6,404,059,000 5,123,962,000 4,757,174,000 4,175,883,000                                    
        amounts presented include balances held by our consolidated variable interest entities, phase 1 holdings, train 4 holdings, and train 5 holdings, as further discussed in note 7 — variable interest entities.
      		                                          
        liabilities and stockholders’ equity
      		                                          
        other non-current liabilities
      		 85,805,000 1,463,000       23,000,000 23,000,000 23,000,000 23,000,000 23,000,000 23,000,000 23,000,000 23,000,000 23,000,000 23,000,000 22,916,000 21,670,000 15,000,000 15,000,000                    
        stockholders’ equity
      		                                          
        non-controlling interest
      		 1,821,862,000 1,421,060,000 1,366,745,000 375,944,000 645,820,000 610,940,000 452,511,000 340,637,000                                  
        amounts presented include balances held by our consolidated variable interest entities, phase 1 holdings and train 4 holdings, as further discussed in note 7 — variable interest entities.
      		                                          
        amounts presented include balances held by our consolidated variable interest entity, intermediate holdings, as further discussed in note 7, variable interest entity.
      		                                          
        operating lease liabilities
      		   2,881,000    3,143,000                                   
        derivative liability
      		       66,899,000                                   
        total stockholders' equity
      		   377,641,000    287,923,000 476,998,000                          5,000,001 5,150,940 5,205,425 5,228,158 5,426,749 5,568,560 5,658,301 5,790,382 
        amounts presented include balances held by our consolidated variable interest entity, intermediate holdings, as further discussed in note 8, variable interest entity.
      		                                          
        debt issuance costs
      		     357,903,000 371,466,000 389,695,000                                   
        common stock warrants
      		      5,297,000                                    
        derivative asset
      		       17,958,000                                   
        liabilities, convertible preferred stock and stockholders’ equity
      		                                          
        common stock warrant liabilities
      		       6,851,000                                   
        series a-c convertible preferred stock
      		                                          
        stockholders’ equity:
      		                                          
        total liabilities, convertible preferred stock and stockholders’ equity
      		       3,323,801,000 2,898,416,000 352,786,000 327,905,000 312,430,000 320,716,000 244,744,000 221,670,000 222,105,000 228,687,000 229,089,000 222,081,000                        
        current assets
      		                                          
        current derivative asset
      		        21,047,000                                  
        debt issuance costs, net of amortization
      		        401,668,000                                  
        non-current derivative assets
      		        130,609,000                                  
        current liabilities
      		                                          
        accrued liabilities and other current liabilities
      		        213,111,000 19,762,000 28,661,000 23,184,000 10,988,000 5,315,000 2,815,000 5,791,000 5,306,000 4,277,000 2,147,000 1,032,000 1,374,000 1,294,000 8,749,000 8,751,000 19,911,000 4,789,000 4,187,000 8,353,000 14,556,000 9,892,000 5,469,000 5,856,000 4,105,000          
        current common stock warrant liabilities
      		        7,359,000 8,702,000 3,504,000    3,291,000 1,376,000 1,330,000 9,168,000 4,520,000 3,290,000 4,655,000                      
        current operating lease liabilities
      		        3,379,000 634,000 873,000 1,093,000 968,000 963,000 440,000 596,000 579,000 504,000 274,000 432,000 596,000 638,000 430,000 698,000 1,512,000 1,784,000 1,320,000                
        non-current common stock warrant liabilities
      		        1,951,000 3,910,000 3,653,000 6,790,000 8,234,000 5,461,000 7,620,000 2,587,000 2,463,000 3,068,000 2,499,000 874,000 1,233,000 4,261,000 3,696,000 12,034,000 10,343,000 11,216,000 7,638,000 7,441,000 7,522,000              
        non-current operating lease liabilities
      		        146,338,000 331,000 395,000 465,000 143,000 364,000   169,000 333,000    166,000  3,000 10,000 273,000 352,000                
        non-current debt, net of unamortized debt issuance costs
      		        1,381,825,000                                  
        series a convertible preferred stock, 1,000 per share liquidation preference; issued and outstanding: none and 82,948 shares at september 30, 2023 and december 31, 2022, respectively
      		                                          
        series b convertible preferred stock, 1,000 per share liquidation preference ; issued and outstanding: none and 79,239 shares at september 30, 2023 and december 31, 2022, respectively
      		                                          
        series c convertible preferred stock, 1,000 per share liquidation preference; issued and outstanding: none and 59,366 shares at september 30, 2023 and december 31, 2022, respectively
      		                                          
        common stock
      		        26,000 16,000 15,000 14,000 14,000 13,000  12,000 12,000 12,000 12,000 12,000 12,000 12,000 12,000 12,000 11,000 11,000 11,000 11,000 11,000 11,000 11,000 11,000 11,000 102,682,223 102,790,445 108,043,938 108,043,938 108,086,324 108,043,938 107,974,997 107,974,997 107,974,997 
        preferred stock, 0.0001 par value authorized: 0.5 million, after designation of the convertible preferred stock issued and outstanding: none at september 30, 2023 and december 31, 2022
      		                                          
        current derivative liability
      		         3,395,000                                 
        non-current derivative liability
      		         84,055,000                                 
        series a convertible preferred stock, 1,000 per share liquidation preference; issued and outstanding: 87,978 shares and 82,948 shares at june 30, 2023 and december 31, 2022, respectively
      		         78,056,000                                 
        series b convertible preferred stock, 1,000 per share liquidation preference ; issued and outstanding: 84,037 shares and 79,239 shares at june 30, 2023 and december 31, 2022, respectively
      		         78,206,000                                 
        series c convertible preferred stock, 1,000 per share liquidation preference; issued and outstanding: 62,959 shares and 59,366 shares at june 30, 2023 and december 31, 2022, respectively
      		         59,602,000                                 
        preferred stock, 0.0001 par value authorized: 0.5 million, after designation of the convertible preferred stock issued and outstanding: none at june 30, 2023 and december 31, 2022
      		                                          
        series a convertible preferred stock, 1,000 per share liquidation preference; issued and outstanding: 85,454 shares and 82,948 shares at march 31, 2023 and december 31, 2022, respectively
      		          75,532,000                                
        series b convertible preferred stock, 1,000 per share liquidation preference; issued and outstanding: 81,629 shares and 79,239 shares at march 31, 2023 and december 31, 2022, respectively
      		          75,798,000                                
        series c convertible preferred stock, 1,000 per share liquidation preference; issued and outstanding: 61,156 shares and 59,366 shares at march 31, 2023 and december 31, 2022, respectively
      		          57,799,000                                
        preferred stock, 0.0001 par value authorized: 0.5 million, after designation of the convertible preferred stock issued and outstanding: none at march 31, 2023 and december 31, 2022
      		                                          
        series a convertible preferred stock, 1,000 per share liquidation preference, issued and outstanding: 82,948 shares and 73,713 shares at december 31, 2022 and 2021, respectively
      		           73,026,000                               
        series b convertible preferred stock, 1,000 per share liquidation preference, issued and outstanding: 79,239 shares and 70,433 shares at december 31, 2022 and 2021, respectively
      		           73,408,000                               
        series c convertible preferred stock, 1,000 per share liquidation preference, issued and outstanding: 59,366 shares and 42,490 shares at december 31, 2022 and 2021, respectively
      		           56,009,000                               
        preferred stock, 0.0001 par value authorized: 0.5 million, after designation of the convertible preferred stock, issued and outstanding: none at december 31, 2022 and 2021
      		                                          
        share-based compensation liability
      		            182,000 182,000 182,000 182,000 182,000 182,000 182,000 182,000 182,000 182,000 182,000 182,000 182,000 182,000 402,000 3,018,000 6,394,000 7,548,000 1,949,000 1,815,000 993,000          
        series a convertible preferred stock, 1,000 per share liquidation preference; issued and outstanding: 80,516 shares and 73,713 shares at september 30, 2022 and december 31, 2021, respectively
      		            70,594,000                              
        series b convertible preferred stock, 1,000 per share liquidation preference; issued and outstanding: 76,922 shares and 70,433 shares at september 30, 2022 and december 31, 2021, respectively
      		            71,091,000                              
        series c convertible preferred stock, 1,000 per share liquidation preference; issued and outstanding: 57,630 shares and 42,490 shares at september 30, 2022 and december 31, 2021, respectively
      		            54,273,000                              
        preferred stock, 0.0001 par value authorized: 0.5 million, after designation of the convertible preferred stock issued and outstanding: none at september 30, 2022 and december 31, 2021
      		                                          
        series a convertible preferred stock, 1,000 per share liquidation preference; issued and outstanding: 78,181 shares and 73,713 shares at june 30, 2022 and december 31, 2021, respectively
      		             68,259,000                             
        series b convertible preferred stock, 1,000 per share liquidation preference ; issued and outstanding: 74,694 shares and 70,433 shares at june 30, 2022 and december 31, 2021, respectively
      		             68,863,000                             
        series c convertible preferred stock, 1,000 per share liquidation preference; issued and outstanding: 55,961 shares and 42,490 shares at june 30, 2022 and december 31, 2021, respectively
      		             52,604,000                             
        preferred stock, 0.0001 par value authorized: 0.5 million, after designation of the convertible preferred stock issued and outstanding: none at june 30, 2022 and december 31, 2021
      		                                          
        series a convertible preferred stock, 1,000 per share liquidation preference; issued and outstanding: 75,938 shares and 73,713 shares at march 31, 2022 and december 31, 2021, respectively
      		              66,016,000                            
        series b convertible preferred stock, 1,000 per share liquidation preference; issued and outstanding: 72,556 shares and 70,433 shares at march 31, 2022 and december 31, 2021, respectively
      		              66,725,000                            
        series c convertible preferred stock, 1,000 per share liquidation preference; issued and outstanding: 54,587 shares and 42,490 shares at march 31, 2022 and december 31, 2021, respectively
      		              51,200,000                            
        other non current assets
      		               21,312,000    16,299,000    6,748,000                   
        series a convertible preferred stock, 1,000 per share liquidation preference, issued and outstanding: 73,713 shares and 65,507 shares at december 31, 2021 and 2020, respectively
      		               63,791,000                           
        series b convertible preferred stock, 1,000 per share liquidation preference, issued and outstanding: 70,433 shares and 62,612 shares at december 31, 2021 and 2020, respectively
      		               64,602,000                           
        series c convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 42,490 shares and no shares at december 31, 2021 and 2020, respectively
      		               40,007,000                           
        preferred stock, 0.0001 par value authorized: 0.5 million, after designation of the convertible preferred stock, issued and outstanding: none at december 31, 2021 and 2020
      		                                          
        series a convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 71,552 shares and 65,507 shares at september 30, 2021 and december 31, 2020, respectively
      		                61,614,000                          
        series b convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 68,373 shares and 62,612 shares at september 30, 2021 and december 31, 2020, respectively
      		                62,542,000                          
        series c convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 41,449 shares and no shares at september 30, 2021 and december 31, 2020, respectively
      		                38,966,000                          
        preferred stock, 0.0001 par value authorized: 0.8 million, after designation of the convertible preferred stock issued and outstanding: none at september 30, 2021 and december 31, 2020
      		                                          
        series a convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 69,477 shares and 65,507 shares at june 30, 2021 and december 31, 2020, respectively
      		                 59,509,000                         
        series b convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 66,396 shares and 62,612 shares at june 30, 2021 and december 31, 2020, respectively
      		                 60,549,000                         
        series c convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 35,190 shares and no shares at june 30, 2021 and december 31, 2020, respectively
      		                 33,173,000                         
        preferred stock, 0.0001 par value authorized: 0.8 million, after designation of the convertible preferred stock issued and outstanding: none at june 30, 2021 and december 31, 2020
      		                                          
        series a convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 67,485 shares and 65,507 shares at march 31, 2021 and december 31, 2020, respectively
      		                  57,516,000                        
        series b convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 64,496 shares and 62,612 shares at march 31, 2021 and december 31, 2020, respectively
      		                  58,665,000                        
        series c convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 24,990 shares and no shares at march 31, 2021 and december 31, 2020, respectively
      		                  23,629,000                        
        preferred stock, 0.0001 par value authorized: 0.8 million, after designation of the series a, series b and series c convertible preferred stock issued and outstanding: none at march 31, 2021 and december 31, 2020
      		                                          
        investment securities
      		                       62,207,000 40,374,000 52,573,000 56,088,000 72,453,000               
        liabilities, series a and series b convertible preferred stock and stockholders’ equity
      		                                          
        series a convertible preferred stock, 1,000 per share liquidation preference, issued and outstanding: 65,507 shares and 58,197 shares at december 31, 2020 and december 31, 2019, respectively
      		                   55,522,000                       
        series b convertible preferred stock, 1,000 per share liquidation preference, issued and outstanding: 62,612 shares and 55,645 shares at december 31, 2020 and december 31, 2019, respectively
      		                   56,781,000                       
        preferred stock, 0.0001 par value authorized: 0.9 million, after designation of the series a and series b convertible preferred stock, issued and outstanding: none at december 31, 2020 and december 31, 2019
      		                                          
        total liabilities, series a and series b convertible preferred stock and stockholders’ equity
      		                   201,668,000 204,867,000 203,429,000 218,777,000 221,195,000 169,828,000 164,677,000 160,842,000 169,002,000 184,689,000              
        series a convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 63,586 shares and 58,197 shares at september 30, 2020 and december 31, 2019, respectively
      		                    53,586,000                      
        series b convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 60,780 shares and 55,645 shares at september 30, 2020 and december 31, 2019, respectively
      		                    54,949,000                      
        preferred stock, 0.0001 par value authorized: 0.9 million, after designation of the series a and series b convertible preferred stock issued and outstanding: none at september 30, 2020 and december 31, 2019
      		                                          
        series a convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 61,743 shares and 58,197 shares at june 30, 2020 and december 31, 2019, respectively
      		                     51,727,000                     
        series b convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 59,023 shares and 55,645 shares at june 30, 2020 and december 31, 2019, respectively
      		                     53,192,000                     
        preferred stock, 0.0001 par value authorized: 0.9 million, after designation of the series a and series b convertible preferred stock issued and outstanding: none at june 30, 2020 and december 31, 2019
      		                                          
        series a convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 59,954 shares and 58,197 shares at march 31, 2020 and balance at december 31, 2019, respectively
      		                      49,917,000                    
        series b convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 57,318 shares and 55,645 shares at march 31, 2020 and balance at december 31, 2019, respectively
      		                      51,487,000                    
        preferred stock, 0.0001 par value authorized: 0.9 million, after designation of the series a and series b convertible preferred stock issued and outstanding: none at march 31, 2020 and december 31, 2019
      		                                          
        series a convertible preferred stock, 1,000 per share liquidation preference, issued and outstanding: 58,197 shares and 51,720 shares at december 31, 2019 and december 31, 2018, respectively
      		                       48,084,000                   
        series b convertible preferred stock, 1,000 per share liquidation preference, issued and outstanding: 55,645 shares and 29,636 shares at december 31, 2019 and december 31, 2018, respectively
      		                       49,814,000                   
        preferred stock, 0.0001 par value authorized: 0.9 million, after designation of the series a and series b convertible preferred stock, issued and outstanding: none at december 31, 2019 and december 31, 2018, respectively
      		                                          
        series a convertible preferred stock, 1,000 per share liquidation preference, issued and outstanding: 56,491 shares and 51,720 shares at september 30, 2019 and december 31, 2018, respectively
      		                        46,186,000                  
        series b convertible preferred stock, 1,000 per share liquidation preference, issued and outstanding: 54,019 shares and 29,636 shares at september 30, 2019 and december 31, 2018, respectively
      		                        48,188,000                  
        preferred stock, 0.0001 par value authorized: 0.9 million, after designation of the series a and series b convertible preferred stock, issued and outstanding: none at september 30, 2019 and december 31, 2018, respectively
      		                                          
        series a convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 54,854 shares and 51,720 shares at june 30, 2019 and december 31, 2018, respectively
      		                         44,263,000                 
        series b convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 52,818 shares and 29,636 shares at june 30, 2019 and december 31, 2018, respectively
      		                         46,987,000                 
        preferred stock, 0.0001 par value authorized: 0.9 million, after designation of the series a and series b convertible preferred stock issued and outstanding: none at june 30, 2019 and december 31, 2018
      		                                          
        series a convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 53,281 shares and 51,720 shares at march 31, 2019 and december 31, 2018, respectively
      		                          43,775,000                
        series b convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 30,555 shares and 29,636 shares at march 31, 2019 and december 31, 2018, respectively
      		                          27,978,000                
        preferred stock, 0.0001 par value authorized: 0.9 million, after designation of the series a and series b convertible preferred stock issued and outstanding: none at march 31, 2019 and december 31, 2018
      		                                          
        non-current compensation liabilities
      		                              1,000,000 2,015,000 2,015,000          
        non-current share-based compensation liability
      		                              3,419,000 2,587,000 1,312,000          
        series a convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 51,720 shares and zero shares at december 31, 2018 and december 31, 2017, respectively
      		                           40,091,000               
        series b convertible preferred stock, 1,000 per share liquidation preference issued and outstanding: 29,636 shares and zero shares at december 31, 2018 and december 31, 2017, respectively
      		                           26,159,000               
        preferred stock, 0.0001 par value authorized: 0.9 million, after designation of the series a and series b convertible preferred stock issued and outstanding: none at december 31, 2018 and december 31, 2017
      		                                          
        accumulated other comprehensive loss
      		                               -40,000 -18,000          
        investments
      		                            60,135,000 5,088,000 5,065,000 5,063,000 5,060,000          
        series a convertible preferred stock, 1,000 per share liquidation preference authorized: 51,000 shares issued and outstanding: 51,000 shares and zero shares at september 30, 2018 and december 31, 2017, respectively
      		                            38,820,000              
        series b convertible preferred stock, 1,000 per share liquidation preference authorized: 51,000 shares issued and outstanding: 29,636 shares and zero shares at september 30, 2018 and december 31, 2017, respectively
      		                            26,159,000              
        preferred stock, 0.0001 par value authorized: 0.9 million, after designation of the series a and series b convertible preferred stock issued and outstanding: none at september 30, 2018 and december 31, 2017
      		                                          
        total liabilities and stockholders’ equity
      		                             112,189,000 111,416,000 116,091,000 118,763,000 114,031,800 113,120,560 117,553,798 117,596,122 117,692,675 117,812,946 117,885,816 118,016,807 118,298,030 
        deferred equity issuance costs
      		                                          
        other assets
      		                                349,000          
        cash
      		                                44,709,000          
        prepaid expenses
      		                                 42,246 58,984 19,721 36,171 48,555 46,687 100,151 154,484 119,345 
        total current assets:
      		                                 92,785 255,501 54,661 149,875 205,977 371,678 480,090 633,570 998,030 
        cash, cash equivalents and securities held in trust
      		                                 113,939,015 112,865,059 117,462,767 117,391,631 117,420,942 117,374,895 117,339,353 117,316,864  
        total assets:
      		                                 114,031,800 113,120,560 117,553,798 117,596,122 117,692,675 117,812,946 117,885,816 118,016,807 118,298,030 
        liabilities & stockholders’ equity
      		                                          
        total current liabilities:
      		                                 484,072 372,495 33,920 21,759 53,193 17,259 17,259 58,509 207,651 
        deferred underwriters fee
      		                                 4,325,000 4,325,000 4,325,000 4,325,000 4,325,000 4,325,000 4,325,000 4,325,000 4,325,000 
        note payable
      		                                 110,047 110,047        
        note payable to stockholders
      		                                 1,430,457         
        commitments
      		                                          
        preferred stock, .0001 par value...
      		                                          
        common stock, .0001 par value...
      		                                 467 457 451 450 450 450 450 450 450 
        additional paid-in capital
      		                                 5,989,175 5,880,964 5,690,808 5,690,809 5,648,423 5,690,809 5,759,750 5,759,750 5,799,448 
        1
      		                                          
        liabilities and stockholders' equity
      		                                          
        notes payable to stockholders
      		                                  522,572        
        stockholders' equity
      		                                          
        prepaid expenses - non-current
      		                                   36,370       
        prepaid expenses - long term
      		                                    54,616 65,756 66,373 66,373 66,373  
        liabilities & stockholders' equity
      		                                          
        deferred offering costs
      		                                          
        offering costs payable
      		                                          
        note payable to stockholder
      		                                         50,000 
        cash and cash equivalents held in trust
      		                                         117,300,000 
        advances from stockholders
      		                                         75,674 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2016-12-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 
                                             
          operating activities:
        		                                     
          net loss
        		-195,040,000                           -10,680,000 -3,482,000 -16,200,000 -16,328,000      -8,193 
          adjustments to reconcile net loss to net cash from operating activities
        		                                     
          depreciation
        		378,000 613,000 614,000 613,000 620,000 84,000 51,000 42,000 37,000 38,000 33,000 40,000 42,000 47,000 48,000 43,000 45,000 48,000 50,000 66,000 64,000 16,000 87,000 79,000 44,000 41,000 44,000 50,000 48,000 29,000 28,000       
          share-based compensation expense
        		5,449,000 6,602,000 6,075,000 4,985,000 4,408,000 4,439,000 4,498,000 9,715,000 10,781,000 1,559,000 3,917,000 3,040,000 2,887,000 -2,372,000 1,258,000 -2,709,000 867,000 -3,729,000 418,000 837,000 264,000 -1,860,000 2,891,000 -4,720,000 -13,155,000 5,338,000 4,109,000 1,480,000 -983,000 12,234,000 12,217,000       
          derivative loss
        		62,110,000 168,700,000                                    
          derivative settlements
        		2,251,000 3,932,000 3,445,000 2,728,000 37,598,000 4,905,000                                
          reduction of right-of-use assets
        		1,093,000                                     
          amortization of debt issuance costs
        		28,378,000 16,916,000 16,267,000 15,979,000 16,702,000 16,388,000 15,720,000                               
          interest elected to be paid-in-kind
        		28,766,000                                     
          other
        		152,000 -158,000 -1,728,000 -1,255,000 3,478,000 98,000                                
          changes in operating assets and liabilities:
        		                                     
          prepaid expenses and other current assets
        		1,706,000 -1,149,000 -1,621,000 782,000 1,089,000 -1,104,000 181,000 -1,070,000                              
          accounts payable
        		2,485,000 2,071,000 -5,482,000 950,000 -1,156,000 3,466,000 744,000 3,004,000 -506,000 815,000 390,000 -138,000 318,000 114,000 -102,000 85,000 36,000 -45,000 108,000 -94,000 -356,000 -28,000 123,000 -462,000 272,000 274,000 166,000 16,000 98,000 -156,000 -327,000 -163,171 96,980 0 -41,250 -23,468 81,977 
          operating lease liabilities
        		-1,127,000 -412,000 -429,000 -397,000 -566,000 -668,000 -509,000 923,000 -303,000 -290,000 -196,000 -216,000 -110,000 -156,000 -152,000 -89,000 -149,000 -158,000 -164,000 -208,000 -231,000 -271,000 -821,000 -537,000              
          accrued expenses and other liabilities
        		-47,435,000 -25,318,000 35,133,000 -25,973,000 10,711,000 5,384,000 -21,538,000 13,901,000 -1,279,000 1,836,000 3,731,000 2,913,000 2,162,000 -2,994,000 554,000 972,000 1,552,000 1,390,000 -611,000 225,000 -119,000 -5,364,000 1,756,000 754,000 547,000 -1,148,000 -3,859,000 5,238,000 965,000 -1,543,000 279,000       
          net cash from operating activities
        		-110,834,000 -68,826,000 -8,903,000 -63,844,000 5,987,000 -28,825,000 -20,993,000 -11,423,000 -18,019,000 -23,185,000 -12,115,000 -10,486,000 -7,281,000 -10,194,000 -5,708,000 -4,552,000 -3,910,000 -3,790,000 -3,507,000 -3,964,000 -4,544,000 -14,238,000 -7,417,000 -8,049,000 -17,227,000 -8,007,000 -10,639,000 -3,585,000 -3,264,000 -5,797,000 -4,838,000 -7,700,022 -107,558   -234,227 -45,561 
          capital expenditures
        		0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0   0 0 
          free cash flows
        		-110,834,000 -68,826,000 -8,903,000 -63,844,000 5,987,000 -28,825,000 -20,993,000 -11,423,000 -18,019,000 -23,185,000 -12,115,000 -10,486,000 -7,281,000 -10,194,000 -5,708,000 -4,552,000 -3,910,000 -3,790,000 -3,507,000 -3,964,000 -4,544,000 -14,238,000 -7,417,000 -8,049,000 -17,227,000 -8,007,000 -10,639,000 -3,585,000 -3,264,000 -5,797,000 -4,838,000 -7,700,022 -107,558   -234,227 -45,561 
          investing activities:
        		                                     
          acquisition of property, plant and equipment
        		-1,176,674,000 -769,971,000 -694,607,000 -505,308,000 -577,554,000 -790,332,000 -741,169,000 -943,514,000 -31,425,000 -21,528,000 -28,080,000 -3,071,000 -1,288,000 -1,314,000 -3,715,000 -2,909,000 -3,097,000 -2,384,000 -2,264,000 -1,925,000 -14,337,000 -13,826,000 -1,694,000 -4,532,000 -8,194,000 -5,883,000 -7,198,000 -3,714,000 -2,569,000 -5,177,000 -4,143,000       
          acquisition of other non-current assets
        		 -9,438,000 0 0 -371,000 -6,033,000 -1,193,000 -10,453,000 -1,643,000 -1,875,000 -1,792,000 -1,735,000 -1,905,000 -1,703,000 -1,763,000 -1,562,000 -1,571,000 -1,533,000 -1,521,000 -1,533,000 -1,750,000 -6,107,000                
          net cash from investing activities
        		-1,176,674,000 -779,409,000 -694,607,000 -505,308,000 -577,925,000 -796,365,000 -742,362,000 -953,967,000 -33,068,000 -23,403,000 -29,872,000 -4,806,000 -3,193,000 -3,017,000 -5,478,000 -4,471,000 -4,668,000 -3,917,000 -3,785,000 -3,458,000 -16,087,000 41,851,000 -30,478,000 7,665,000 -4,558,000 10,678,000 -19,601,000 -58,764,000 -2,595,000 -5,201,000 -4,168,000 12,128,521 36,483   0 -117,300,000 
          financing activities:
        		                                     
          proceeds from debt issuance
        		817,000,000 645,000,000 724,353,000 498,336,000 1,531,673,000 768,881,000 674,000,000                               
          receipt of equity commitments
        		248,666,000 215,000,000 182,667,000 160,000,000 138,706,000 194,627,000                                
          debt issuance costs
        		-20,165,000 -18,330,000  -16,066,000                                  
          shares repurchased related to share-based compensation
        		-18,000 -49,000 -125,000 -6,424,000 -59,000 -94,000 -20,000 -9,537,000 -23,000 -47,000 -460,000 -1,060,000 -1,288,000 -464,000 -5,000 -139,000 -96,000 -44,000 -24,000 -211,000 -54,000 -57,000 0 -219,000 -171,000 -260,000 -16,000           
          net cash from financing activities
        		1,045,483,000 841,621,000 830,474,000 631,871,000 523,619,000 782,110,000 611,974,000 1,371,237,000 39,958,000 34,940,000 -4,447,000 84,015,000 28,616,000 10,017,000 -5,000 5,171,000 9,883,000 24,389,000 -33,000 -224,000 -69,000 14,930,000 49,790,000 -318,000 20,759,000 -271,000 -471,000    0   0 0 -165,372 118,223,131 
          net decrease in cash, cash equivalents and restricted cash
        		-242,025,000    -48,319,000 -43,080,000                                
          cash, cash equivalents and restricted cash – beginning of period
        		707,088,000 392,761,000 0 0 0 294,478,000                                
          cash, cash equivalents and restricted cash – end of period
        		465,063,000 386,147,000 126,964,000 62,719,000 -48,319,000 251,398,000                                
          net loss attributable to nextdecade corporation
        		        -120,289,000 -27,347,000 -18,925,000 -18,797,000 -10,912,000 -11,437,000 -8,023,000 1,222,000 -11,580,000 -3,658,000 -2,279,000 -7,178,000   -13,881,000 -3,228,000 -6,719,000 -12,043,000            
          adjustment to reconcile net loss to net cash from operating activities
        		                                     
          amortization of leases
        		                                     
          loss on extinguishment of debt
        		  1,741,000 0 40,133,000 7,440,000                                
          corporate fixed asset retirements
        		 3,518,000                                    
          operating leases
        		                                     
          repayment of debt
        		  -56,243,000 0 -1,106,000,000 -176,000,000                                
          costs associated with repayment of debt
        		  0 -3,975,000 -8,453,000 -995,000                                
          net increase in cash, cash equivalents and restricted cash
        		 -6,614,000 126,964,000                                   
          balance per consolidated balance sheets:
        		                                     
          cash and cash equivalents
        		 130,938,000 109,907,000 88,000 -7,611,000 45,753,000 -12,606,000                               
          restricted cash
        		 255,209,000 17,057,000 62,631,000 -40,708,000 205,645,000 -138,775,000                               
          total cash, cash equivalents and restricted cash
        		 386,147,000  62,719,000 -48,319,000 251,398,000 -151,381,000                               
          net income attributable to nextdecade corporation
        		 -245,228,000 481,443,000 -393,075,000 2,304,000 186,775,000                902,000                
          adjustment to reconcile net income to net cash from operating activities
        		                                     
          amortization of right-of-use assets
        		 1,087,000 1,086,000 1,086,000 1,249,000 1,324,000 2,410,000 47,000 265,000 258,000 234,000 192,000 190,000 140,000 137,000 133,000 142,000 139,000 246,000 329,000 331,000 324,000                
          loss on common stock warrant liabilities
        		     1,516,000 -641,000 -3,302,000 5,455,000 367,000 -1,445,000 2,774,000 -1,886,000 6,304,000 170,000 -4,443,000 4,768,000 2,038,000 -1,723,000 1,627,000   1,692,000 -873,000 1,641,000 197,000            
          gain on sale of assets
        		      308,000                               
          proceeds from sale of common stock
        		      0 179,400,000 40,000,000 35,000,000 0 85,000,000   168,000                       
          debt and equity issuance costs
        		     -4,309,000 -3,310,000                               
          preferred stock dividends
        		      0 -21,000 -19,000 -13,000 -37,000 1,000 -20,000 -19,000 -17,000 -23,000 -14,000 -13,000 -9,000 -13,000 -15,000 -13,000 -12,000 -4,000 -15,000 -11,000            
          total cash, cash equivalents and restricted cash per consolidated balance sheet
        		                                     
          derivative gain
        		   329,733,000 -109,067,000 -258,872,000                                
          net cash from settlement of derivative instruments
        		      2,978,000                               
          loss on debt extinguishment
        		                                     
          interest expense
        		      23,503,000                               
          amortization of other non-current assets
        		          0 0 0 354,000 354,000 354,000 354,000 354,000 318,000 354,000 511,000 177,000                
          proceeds from sale of equity in subsidiaries
        		                                     
          proceeds from sale of preferred stock
        		                                     
          balance per consolidated balance sheet:
        		                                     
          proceeds from sale of equity in intermediate holdings
        		                                     
          proceeds from sale of rio bravo pipeline, llc
        		                                     
          proceeds from sale of series c convertible preferred stock
        		          0 0 0 10,500,000 0 5,000,000                      
          net increase in cash and cash equivalents
        		       405,847,000   -46,434,000 68,723,000 18,142,000 -3,194,000 -11,191,000 -3,852,000 1,305,000 16,682,000 -7,325,000 -7,646,000 -20,700,000 42,543,000 11,895,000 -702,000 -1,026,000 2,400,000 -30,711,000 15,034,000     -11,075 -54,948 -99,147 -399,599 877,570 
          cash and cash equivalents – beginning of period
        		       0 0 62,789,000 0 0 0 25,552,000 0 0 0 22,608,000 0 0 0 15,736,000 0 0 0 3,169,000 0 0 0 35,703,000        
          cash and cash equivalents – end of period
        		       405,847,000 -11,129,000 51,141,000 -46,434,000 68,723,000 18,142,000 22,358,000 -11,191,000 -3,852,000 1,305,000 39,290,000 -7,325,000 -7,646,000 -20,700,000 58,279,000 11,895,000 -702,000 -1,026,000 5,569,000 -30,711,000 15,034,000 -5,859,000 24,705,000        
          equity issuance costs
        		          -3,950,000 74,000   -151,000 -56,000 -7,000 -54,000     -198,000    -451,000    0       
          non-cash investing activities:
        		                                     
          accounts payable for acquisition of property, plant and equipment
        		        6,994,000 72,000 -308,000 -307,000 438,000 339,000 -212,000 311,000 -61,000 79,000 -463,000 137,000 -2,999,000 3,341,000 10,387,000 6,000 94,000 864,000 -289,000 203,000 278,000 175,000 -768,000       
          accrued liabilities for acquisition of property, plant and equipment
        		         15,826,000 8,142,000 2,677,000 388,000 839,000 -70,000 21,000 580,000 395,000 268,000 -147,000 -7,333,000 7,862,000 -12,813,000 14,258,000 -33,000 1,091,000 -2,042,000 -874,000 2,459,000 4,471,000 1,472,000       
          accrued liabilities for acquisition of other non-current assets
        		        317,000 140,000                            
          non-cash financing activities:
        		                                     
          paid-in-kind dividends on convertible preferred stock
        		        6,735,000 6,686,000 6,485,000 6,232,000 5,755,000 5,735,000 5,262,000                       
          accounts payable for debt and equity issuance costs
        		                                     
          accrued liabilities for debt and equity issuance costs
        		                                     
          prepaid expenses
        		         -421,000 146,000 -294,000 28,000 -194,000 48,000 -120,000 55,000 -169,000 130,000 78,000 201,000 -218,000 250,000 665,000 129,000 -471,000       35,676   -101,512 -119,345 
          net decrease in cash and cash equivalents
        		         -11,648,000                    -10,998,000        
          accounts payable for equity issuance costs
        		           3,879,000                          
          pipeline assets obtained in exchange for other non-current liabilities
        		              0 0 0 84,000 1,246,000                   
          accretion of deemed dividends on series a convertible preferred stock
        		              16,000 16,000 15,000 16,000 15,000 16,000 21,000 76,000 193,000 285,000 488,000 551,000            
          accrued liabilities for equity issuance costs
        		             50,000 0                       
          realized loss on investment securities
        		                  0 0 0 423,000                
          proceeds from sale of investment securities
        		                  0 0 0 61,972,000 28,500,000 12,500,000 19,000,000 17,000,000            
          purchase of investment securities
        		                  0 0 0 -188,000 -50,409,000 -303,000 -15,364,000 -439,000            
          proceeds from sale of rio bravo pipeline company, llc
        		                                     
          proceeds from sale of rio bravo
        		                   0 0 15,000,000                
          paid-in-kind dividends on series a and series b convertible preferred stock
        		                3,862,000 3,862,000  3,600,000 3,494,000 3,430,000  2,839,000 2,461,000 2,491,000            
          proceeds from equity issuance
        		                 24,500,000     50,000,000 0   0           
          gain on investment securities
        		                                     
          common stock issued in lieu of cash
        		                                     
          paid-in-kind dividends on series a convertible preferred stock
        		                                     
          gain on common stock warrant liabilities
        		                     -8,339,000     -81,000           
          dividends payable on series a and series b convertible preferred stock charged to additional paid-in capital
        		                         2,481,000            
          loss on investment securities
        		                      176,000 4,000 -96,000 -184,000 86,000 3,000 3,000 22,000        
          realized gain on investment securities
        		                      -99,000 -5,000 -23,000 -11,000            
          other current assets
        		                                     
          amortization of right-of-use asset
        		                       274,000              
          issuance of note receivable
        		                              0       
          repayment of note receivable
        		                              0       
          cash received in reverse recapitalization
        		                              0       
          payment of convertible preferred stock cash dividends
        		                                     
          prepaid expenses and other currents assets
        		                           391,000 87,000 -183,000 -1,056,000       
          purchase of investments
        		                                     
          accretion of deemed dividends series a convertible preferred stock
        		                                     
          investments
        		                            -26,000 -24,000 -25,000       
          accrued liability for deferred financing cost
        		                                     
          impairment loss on capital projects
        		                                     
          other assets
        		                                     
          proceeds from equity issuances
        		                              0       
          dividends paid
        		                                     
          cash, cash equivalents and restricted cash – beginning of year
        		                                     
          cash, cash equivalents and restricted cash – end of year
        		                                     
          balances per consolidated balance sheets:
        		                                     
          changes in operating assets and liabilities
        		                                     
          change in restricted cash
        		                                     
          net increase in cash
        		                                     
          cash – beginning of the period
        		                                     
          cash – end of the period
        		                                     
          cash flows from operating activities
        		                                     
          net income
        		                                -158,889     
          adjustments to reconcile net income to net cash from operations:
        		                                     
          interest earned on cash and securities in trust
        		                                -81,325     
          cash flows from investing activities
        		                                     
          addition to principal in the trust account
        		                                     
          cash withdrawn from trust account
        		                                     
          cash flows from financing activities
        		                                     
          proceeds from note payable and notes payable to stockholders
        		                                     
          redemption of common stock
        		                                     
          net cash (used in) financing activities
        		                                     
          cash and cash equivalents at beginning of period
        		                                0 0 0 0 1,115 
          cash and cash equivalents at end of period
        		                                -11,075 -54,948 -99,147 -399,599 878,685 
          supplemental disclosure of non-cash investing and financing activities
        		                                     
          change in value of ordinary shares subject to possible conversion
        		                                     
          change in value of common stock subject to possible conversion
        		                                     
          withdrawal of trust funds to pay taxes
        		                                36,483     
          investment in cash, cash equivalents and securities in trust account
        		                                     
          payment of offering costs
        		                                   -39,698 -43,208 
          payment of deferred offering costs associated with initial public offering
        		                                     
          note payable to stockholder
        		                                     
          proceeds from sale of shares of common stock to initial stockholders
        		                                     
          proceeds from public offering, net of offering costs
        		                                 0 0 0 112,605,665 
          proceeds from insider units
        		                                 0 0 0 5,585,000 
          accrual of deferred underwriting fee
        		                                 0    
          accrual of deferred offering costs
        		                                     
          payment of note to stockholder
        		                                     
          adjustments to reconcile net income to net cash used by operations:
        		                                     
          proceeds from note payable, stockholder
        		                                     
          deferred offering costs associated with initial public offering
        		                                     
          cash received from initial stockholder
        		                                     
          adjustments to reconcile net loss to net cash from operations:
        		                                     
          investment in restricted cash and cash equivalents
        		                                    -117,300,000 
          proceeds from advances from stockholders
        		                                    75,674 
          accrual of deferred offering cost
        		                                    4,325,000